BoAn Biotechnology (06955.HK) Surges 15% Intraday on HKD 200M Share Buyback Plan and Macau Approval of World’s First Dulaglutide Biosimilar BA5101
May 19, 2026 10:35
CST Updated
11:10
BoAn Biotech
Integrated Biopharmaceutical R&D and Manufacturing Company